Samuel Katsuyuki Shinjo

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad et al. · Nature Medicine · 2021 · 214 citations

Vaccination, Rheumatology, Vaccine Safety +10

Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort

Samuel Katsuyuki Shinjo, Eloísa Bonfá, Daniel Wojdyla et al. · Arthritis & Rheumatism · 2010 · 209 citations · Full text

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis

Marcela Gran Pina Cruellas, Vilma dos Santos Trindade Viana, Maurício Levy‐Neto et al. · Clinics · 2013 · 155 citations · Full text

Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis

Samuel Katsuyuki Shinjo, Rosa Maria Rodrigues Pereira, Vivian A. P. Tizziani et al. · Clinical Rheumatology · 2007 · 114 citations

Rheumatology, Steroid Dosage, Moxibustion +5

Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study

Saulo Gil, Wilson Jacob Filho, Samuel Katsuyuki Shinjo et al. · Journal of Cachexia Sarcopenia and Muscle · 2021 · 109 citations · Full text